Cargando…

Influence of lifestyle choices on risks of CYP1B1 polymorphisms for prostate cancer

Cytochrome P450 1B1 (CYP1B1) converts xenobiotics to carcinogens and how lifestyle choices may interact with CYP1B1 polymorphisms and affect prostate cancer risk was assessed. Blood genomic DNA from a Caucasian population was analysed at polymorphic sites of the 5′ untranslated region of CYP1B1 usin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kato, Taku, Hashimoto, Yutaka, Wong, Ryan K., Mitsui, Yozo, Maekawa, Shigekatsu, Chang, Inik, Shahryari, Varahram, Yamamura, Soichiro, Majid, Shahana, Saini, Sharanjot, Tabatabai, Z. Laura, Dahiya, Rajvir, Deguchi, Takashi, Tanaka, Yuichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156244/ https://www.ncbi.nlm.nih.gov/pubmed/30133114 http://dx.doi.org/10.1111/jcmm.13696

Ejemplares similares

Suppressor effect of catechol-O-methyltransferase gene in prostate cancer
por: Hashimoto, Yutaka, et al.
Publicado: (2021)

Loss of miR-200c up-regulates CYP1B1 and confers docetaxel resistance in renal cell carcinoma
por: Chang, Inik, et al.
Publicado: (2015)

Functional role and tobacco smoking effects on methylation of CYP1A1 gene in prostate cancer
por: Mitsui, Yozo, et al.
Publicado: (2016)

LncRNA CDKN2B-AS1/miR-141/cyclin D network regulates tumor progression and metastasis of renal cell carcinoma
por: Dasgupta, Pritha, et al.
Publicado: (2020)

Differential expression of miR-34b and androgen receptor pathway regulate prostate cancer aggressiveness between African-Americans and Caucasians
por: Shiina, Marisa, et al.
Publicado: (2016)

The role of miR-24 as a race related genetic factor in prostate cancer
por: Hashimoto, Yutaka, et al.
Publicado: (2017)

CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinoma
por: Mitsui, Yozo, et al.
Publicado: (2015)

Correction: CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinoma
por: Mitsui, Yozo, et al.
Publicado: (2022)

Inactivation of bone morphogenetic protein 2 may predict clinical outcome and poor overall survival for renal cell carcinoma through epigenetic pathways
por: Mitsui, Yozo, et al.
Publicado: (2015)

MicroRNA-1280 Inhibits Invasion and Metastasis by Targeting ROCK1 in Bladder Cancer
por: Majid, Shahana, et al.
Publicado: (2012)

MicroRNA-383 located in frequently deleted chromosomal locus 8p22 regulates CD44 in prostate cancer
por: Bucay, Nathan, et al.
Publicado: (2016)

Correction: Up-Regulation of MicroRNA-21 Correlates with Lower Kidney Cancer Survival
por: Zaman, Mohd Saif, et al.
Publicado: (2012)

Novel tumor suppressor microRNA at frequently deleted chromosomal region 8p21 regulates Epidermal Growth Factor Receptor in prostate cancer
por: Bucay, Nathan, et al.
Publicado: (2016)

Genistein Suppresses Prostate Cancer Growth through Inhibition of Oncogenic MicroRNA-151
por: Chiyomaru, Takeshi, et al.
Publicado: (2012)

MicroRNA-4723 Inhibits Prostate Cancer Growth through Inactivation of the Abelson Family of Nonreceptor Protein Tyrosine Kinases
por: Arora, Sumit, et al.
Publicado: (2013)

MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2
por: Colden, Melissa, et al.
Publicado: (2017)

Genistein Up-Regulates Tumor Suppressor MicroRNA-574-3p in Prostate Cancer
por: Chiyomaru, Takeshi, et al.
Publicado: (2013)

Oncogenic microRNA-4534 regulates PTEN pathway in prostate cancer
por: Nip, Hannah, et al.
Publicado: (2016)

MicroRNA-23b Functions as a Tumor Suppressor by Regulating Zeb1 in Bladder Cancer
por: Majid, Shahana, et al.
Publicado: (2013)

DNA mismatch repair gene MLH1 induces apoptosis in prostate cancer cells
por: Fukuhara, Shinichiro, et al.
Publicado: (2014)

Up-Regulation of MicroRNA-21 Correlates with Lower Kidney Cancer Survival
por: Zaman, Mohd Saif, et al.
Publicado: (2012)

Role of miR-182/PDCD4 axis in aggressive behavior of prostate cancer in the African Americans
por: Shiina, Marisa, et al.
Publicado: (2021)

Functional role of DNA mismatch repair gene PMS2 in prostate cancer cells
por: Fukuhara, Shinichiro, et al.
Publicado: (2015)

Inhibition of PTEN Gene Expression by Oncogenic miR-23b-3p in Renal Cancer
por: Zaman, Mohd Saif, et al.
Publicado: (2012)

Genistein Inhibits Prostate Cancer Cell Growth by Targeting miR-34a and Oncogenic HOTAIR
por: Chiyomaru, Takeshi, et al.
Publicado: (2013)

Silibinin suppresses bladder cancer through down-regulation of actin cytoskeleton and PI3K/Akt signaling pathways
por: Imai-Sumida, Mitsuho, et al.
Publicado: (2017)

Cytochrome P450 1B1 inhibition suppresses tumorigenicity of prostate cancer via caspase-1 activation
por: Chang, Inik, et al.
Publicado: (2017)

Correction: Cytochrome P450 1B1 inhibition suppresses tumorigenicity of prostate cancer via caspase-1 activation
por: Chang, Inik, et al.
Publicado: (2018)

MicroRNA-34a Modulates c-Myc Transcriptional Complexes to Suppress Malignancy in Human Prostate Cancer Cells
por: Yamamura, Soichiro, et al.
Publicado: (2012)

Diet, MicroRNAs and Prostate Cancer
por: Saini, Sharanjot, et al.
Publicado: (2010)

Wnt signaling pathways in urological cancers: past decades and still growing
por: Majid, Shahana, et al.
Publicado: (2012)

MicroRNA-182-5p Promotes Cell Invasion and Proliferation by Down Regulating FOXF2, RECK and MTSS1 Genes in Human Prostate Cancer
por: Hirata, Hiroshi, et al.
Publicado: (2013)

Oncogenic miRNA-182-5p Targets Smad4 and RECK in Human Bladder Cancer
por: Hirata, Hiroshi, et al.
Publicado: (2012)

MicroRNAs and epithelial-mesenchymal transition in prostate cancer
por: Sekhon, Kirandeep, et al.
Publicado: (2016)

MicroRNA determinants of neuroendocrine differentiation in metastatic castration-resistant prostate cancer
por: Bhagirath, Divya, et al.
Publicado: (2020)

Interaction and cross-talk between non-coding RNAs
por: Yamamura, Soichiro, et al.
Publicado: (2017)

Extracellular activation of Wnt signaling through epigenetic dysregulation of Wnt inhibitory factor-1 (Wif-1) is associated with pathogenesis of adrenocortical tumor
por: Mitsui, Yozo, et al.
Publicado: (2014)

Versican is a potential therapeutic target in docetaxel-resistant prostate cancer
por: Arichi, Naoko, et al.
Publicado: (2015)

Genistein downregulates onco-miR-1260b and upregulates sFRP1 and Smad4 via demethylation and histone modification in prostate cancer cells
por: Hirata, H, et al.
Publicado: (2014)

Correction: Genistein downregulates onco-miR-1260b and upregulates sFRP1 and Smad4 via demethylation and histone modification in prostate cancer cells
por: Hirata, H, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2mos378rtsud2cmsug877bcmv2